MTEM: Molecular Templates Corporation Year-over-year earnings per share growth for the last twelve months

Public company logo of Molecular Templates Inc (MTEM)

Molecular Templates biopharmaceutical development is protected by international humanitarian medical status, which eliminates geopolitical risks. Tracking quarterly EPS growth confirms this stability, with the 56.90 level serving as a critical benchmark. The company's potential is based on the ETB platform with inelastic demand, while high research scalability promises superprofits upon the mass production of therapeutic toxins in global markets.

Molecular Templates Inc (MTEM) - Quarterly EPS earnings growth from 07/04/2022 to 12/28/2024

Analytical breakdowns for mtem.com (MTEM)

- market value and analyst target forecast:
Price Chart Molecular Templates, Inc.|MTEM - Forecast Levels Chart
- market capitalization information:
Market Value Molecular Templates|MTEM - Total Company Value
- book capitalization data:
Book Value per Share Molecular Templates|MTEM - Book Capitalization|Market Cap to Net Assets Ratio mtem.com|MTEM - Aggregate Business Assets
- debt burden and liquidity indicators:
Total Debt to Capital Molecular Templates|MTEM - Long-Term Liabilities to Equity|Short-Term Debt to Equity Molecular Templates Corporation|MTEM - Company Cumulative Debt|Debt to Book Capitalization Ratio Molecular Templates, Inc.|MTEM - Company Long-Term Loans and Borrowings|Company Short-Term Debt Molecular Templates|Quick Liquidity mtem.com
- earnings and valuation multiples indicators:
MTEM - Net Financial Result|Expected Profit Molecular Templates|MTEM - Price to Earnings Ratio|Future Price to Earnings Molecular Templates Inc|MTEM - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Molecular Templates|MTEM - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Molecular Templates|MTEM - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth mtem.com|MTEM - Net earnings per share growth this year|Expected earnings per share growth for next year Molecular Templates
- revenue and sales details:
MTEM - Revenue and Sales Volume|Company Projected Revenue Molecular Templates Corp|MTEM - Price-to-Revenue Ratio|Forward P/S Multiple Molecular Templates Corporation
Comprehensive company analysis:Molecular Templates
Flagship merchandise of Molecular Templates

For Molecular Templates (MTEM), whose model depends on costly research and side-effect risks, the relative growth of quarterly EPS serves as an indicator of operational resilience. This metric measures the percentage change in net income per share between the current and previous quarters, allowing this chart to identify hidden financial imbalances and avoid unjustified capital freezes.

Who Molecular Templates competes with

Geron (GERN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months NBTX (Nanobiotix Group)|Year-over-year earnings per share growth for the last twelve months Bicycle Therapeutics|Year-over-year earnings per share growth for the last twelve months CTMX|Quarterly EPS earnings growth CATX|Quarterly EPS earnings growth Genelux Corp (GNLX)|Molecular Partners AG - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ONCY (Oncolytics)|Lisata Therapeutics - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months MBRX|galeratx.com (GRTX) - Year-over-year earnings per share growth for the last twelve months